March 2026
1. RINALDI M, Miani B, Gibertoni D, Di Chiara M, et al
   Targeted peri-operative prophylaxis in patients colonized with Carbapenem Resistant Enterobacterales undergoing Liver Transplantation: a multinational cohort study.
   Clin Infect Dis. 2026 Mar 25:ciag185. doi: 10.1093.
   

   >> Share

   
   
2. KISHIDA T, Ikeuchi K, Matsumoto S, Shinohara T, et al
   Persistent Fever and Back Pain After Liver Transplantation.
   Clin Infect Dis. 2026;82:522-525.
   

   >> Share

   
   April 2025
3. BIRABAHARAN M
   Vancomycin-Resistant Enterococci-Active Perioperative Prophylaxis for Liver Transplant Patients Requires Attention to the Gut Microbiota.
   Clin Infect Dis. 2025 Apr 22:ciaf168. doi: 10.1093.
   

   >> Share

   
   March 2025
4. BURASTERO GJ, Wey EQ, Guidetti V, Cantergiani S, et al
   Impact of VRE-active perioperative prophylaxis in liver transplant patients colonized by Vancomycin-Resistant Enterococci.
   Clin Infect Dis. 2025 Mar 14:ciaf121. doi: 10.1093.
   

   >> Share

   
   February 2024
5. KITT E, Stephens-Shields AJ, Huang YV, Bitterman T, et al
   The Comparative Effectiveness of Perioperative Antibiotic Regimens to Prevent Surgical Site Infections in Pediatric Liver Transplant Recipients.
   Clin Infect Dis. 2024 Feb 21:ciae095. doi: 10.1093.
   

   >> Share

   
   January 2024
6. YATES TA, Halliday N
   Re: Association of CMV DNAemia with Long-Term Mortality in a Randomized Trial of Preemptive Therapy (PET) and Antiviral Prophylaxis (AP) for Prevention of CMV Disease in High-Risk Donor Seropositive, Recipient Seronegative (D+R-) Liver Transplant Reci
   Clin Infect Dis. 2024 Jan 9:ciae004. doi: 10.1093.
   

   >> Share

   
   
7. KUMAR L, Dasgupta S, Murray-Krezan C, Singh N, et al
   Response to Yates and Halliday regarding CMV DNAemia and time-to-mortality in a Randomized Trial of PET vs AP in CMV D+R-Liver Transplant Recipients.
   Clin Infect Dis. 2024 Jan 8:ciae005. doi: 10.1093.
   

   >> Share

   
   October 2023
8. KUMAR L, Dasgupta S, Murray-Krezan C, Singh N, et al
   Association of CMV DNAemia with Long-Term Mortality in a Randomized Trial of Preemptive Therapy (PET) and Antiviral Prophylaxis (AP) for Prevention of CMV Disease in High-Risk Donor Seropositive, Recipient Seronegative (D+R-) Liver Transplant Recipien
   Clin Infect Dis. 2023 Oct 20:ciad643. doi: 10.1093.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share